John M - Search Results

1

Assessment of immune function by lymphoproliferation underestimates lymphocyte functional capacity in HIV patients treated with highly active antiretroviral therapy.

Keane NM, Price P, Stone SF, John M, Murray RJ, French MA. Keane NM, et al. Among authors: john m. AIDS Res Hum Retroviruses. 2000 Dec 10;16(18):1991-6. doi: 10.1089/088922200750054729. AIDS Res Hum Retroviruses. 2000. PMID: 11153082

2

Highly active antiretroviral therapy.

French M, Lenzo N, John M, Mallal S, Price P. French M, et al. Among authors: john m. Lancet. 1998 Apr 4;351(9108):1056-7; author reply 1058-9. doi: 10.1016/S0140-6736(05)79021-8. Lancet. 1998. PMID: 9546530 No abstract available.

3

Exacerbation of the inflammatory response to Mycobacterium tuberculosis after antiretroviral therapy.

John M, French MA. John M, et al. Med J Aust. 1998 Nov 2;169(9):473-4. doi: 10.5694/j.1326-5377.1998.tb123372.x. Med J Aust. 1998. PMID: 9847899

4

Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease?

John M, Flexman J, French MA. John M, et al. AIDS. 1998 Dec 3;12(17):2289-93. doi: 10.1097/00002030-199817000-00010. AIDS. 1998. PMID: 9863871

5

High circulating levels of soluble CD30 correlate with impaired delayed-type hypersensitivity responses in HIV-infected patients.

Price P, Murray RJ, John M, French MA. Price P, et al. Among authors: john m. AIDS. 1999 Nov 12;13(16):2308-9. doi: 10.1097/00002030-199911120-00017. AIDS. 1999. PMID: 10563720 No abstract available.

6

Nephrotic syndrome in a patient with IgA deficiency-associated mesangioproliferative glomerulonephritis.

John M, Lam M, Latham B, Saker B, French MA. John M, et al. Pathology. 2000 Feb;32(1):56-8. doi: 10.1080/003130200104600. Pathology. 2000. PMID: 10740809

7

Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy.

John M, Moore CB, James IR, Nolan D, Upton RP, McKinnon EJ, Mallal SA. John M, et al. AIDS. 2001 Apr 13;15(6):717-23. doi: 10.1097/00002030-200104130-00007. AIDS. 2001. PMID: 11371686

8

Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir.

Nolan D, Upton R, McKinnon E, John M, James I, Adler B, Roff G, Vasikaran S, Mallal S. Nolan D, et al. Among authors: john m. AIDS. 2001 Jul 6;15(10):1275-80. doi: 10.1097/00002030-200107060-00009. AIDS. 2001. PMID: 11426072

9

Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy.

French MA, Lenzo N, John M, Mallal SA, McKinnon EJ, James IR, Price P, Flexman JP, Tay-Kearney ML. French MA, et al. Among authors: john m. HIV Med. 2000 Mar;1(2):107-15. doi: 10.1046/j.1468-1293.2000.00012.x. HIV Med. 2000. PMID: 11737333 Free article.

10

Endothelial function in HIV-infected patients receiving protease inhibitor therapy: does immune competence affect cardiovascular risk?

Nolan D, Watts GF, Herrmann SE, French MA, John M, Mallal S. Nolan D, et al. Among authors: john m. QJM. 2003 Nov;96(11):825-32. doi: 10.1093/qjmed/hcg145. QJM. 2003. PMID: 14566037

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,180 results

Search Page

Filters